Physician profile
Michael Sleet
NPI 1932357878
$5,968.20
in general payments reported to CMS, 2019-2025
21 companies · $28.16 in 2025
The $28.16 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $42.91 · 2022: $140 · 2023: $82.16 · 2024: $5,270 · 2025: $28.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $2,206 · Food and Beverage: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $2,206.47 |
| Food and Beverage | $673.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,101.93 | 2023-2024 | Da Vinci Surgical System |
| Ethicon US, LLC | $210.06 | 2019 | |
| Portola Pharmaceuticals, LLC | $145.13 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $83.66 | 2024 | Gore Synecor Biomaterial |
| Kerecis Limited | $42.92 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Hemosonics LLC | $40.35 | 2024 | Quantra Qplus System, Qunatra Qplus System |
| Integra Lifesciences Corporation | $38.75 | 2022 | |
| Masimo Corporation | $30.45 | 2022 | |
| Acera Surgical, INC. | $28.16 | 2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $27.70 | 2023 | Grafix Pl |
| Zimmer Biomet Holdings, INC. | $27.23 | 2022 | |
| Tei Biosciences INC | $27.16 | 2019 | |
| Hydrofera LLC | $26.32 | 2022-2023 | Hydrofera Blue |
| Teleflex LLC | $22.07 | 2023 | Titan Sgs Standard Gastric Stapler |
| Astrazeneca Pharmaceuticals Lp | $19.86 | 2024 | Andexxa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $19.50 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $18.85 | 2019 | |
| Solventum Corporation | $17.78 | 2024 | V.A.C. Veraflo Cleanse Choice, Activ.A.C., Prevena |
| Merck Sharp & Dohme LLC | $15.37 | 2019 | |
| Gilead Sciences, INC. | $12.81 | 2022 | |
| Acadia Pharmaceuticals INC | $12.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sleet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.